Everlywell, a digital health startup connecting consumers to laboratories for more than 35 low-cost, validated lab tests, announced Dec. 6 the addition of several hospital and health system leaders to its scientific advisory board.
The board is led by Robert Langer, ScD, a professor at the Cambridge-based Massachusetts Institute of Technology and a National Medal of Science recipient.
New additions to the scientific advisory board include Betsy Nabel, MD, president of Boston-based Brigham Health; Martin Chavez, MD, chief of maternal fetal medicine at Mineola, N.Y.-based NYU Winthrop Hospital; Naglaa Rizk, MD, medical director of ambulatory services at Paramus, N.J.-based Bergen New Bridge Medical Center; and Marie McDonnell, MD, chief of the diabetes section at Brigham and Women's Hospital in Boston.
Beyond these hospital leaders, other new members of the board represent healthcare organizations such as Roche Diagnostics and the New York State Department of Health, and include Mark DePristo, PhD, CEO and founder of BigHat Biosciences and founder of the genomics team within Google's artificial intelligence-focused Google Brain division.